Company newsForm 8-K
Eli Lilly LLY
Eli Lilly shareholders elect four directors at May 4 annual meeting
Proposals to eliminate the classified board and supermajority voting did not reach the 80% vote required.
GetSignal
Free on iOS and Android
Eli Lilly's annual meeting of shareholders on May 4, 2026 elected four directors to three-year terms ending at the 2029 annual meeting.
Shareholders approved, on an advisory basis, executive pay and ratified Ernst & Young LLP as auditor for 2026. Proposals for an independent board chair and an annual lobbying report were not approved.
Key facts
- Meeting date
- May 4, 2026
- Shares voted
- 847,254,010, approximately 90% of shares entitled to vote
- Director terms end
- 2029 annual meeting
Source: Form 8-K filed May 7, 2026.
Written by GetSignal with AI from the company's SEC filing.
Not investment advice.
More company news
Eli Lilly first, then the newest- Florida Power & Light doubles Saving Steps funding to $30 million
NEE · NextEra Energy · Company release ·